Edition:
India

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

6.15USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$6.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
99,988
52-wk High
$22.38
52-wk Low
$5.20

Select another date:

Thu, May 24 2018

BRIEF-Melinta Therapeutics Prices Public Offering Of 22.0 Mln Shares At $5/Share

* MELINTA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

BRIEF-Melinta Therapeutics Announces Proposed Offering Of Common Stock

* MELINTA THERAPEUTICS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

BRIEF-Melinta Therapeutics Q1 Loss Per Share $0.95

* MELINTA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Melinta Therapeutics Q4 Loss Per Share $1.48

* MELINTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application For Delafloxacin In Europe

* MELINTA THERAPEUTICS PARTNER, MENARINI GROUP, SUBMITS MARKETING AUTHORIZATION APPLICATION FOR DELAFLOXACIN IN EUROPE

BRIEF-Melinta Therapeutics Launches Antibiotic Baxdela In U.S.

* MELINTA THERAPEUTICS LAUNCHES ANTIBIOTIC BAXDELA™ (DELAFLOXACIN) IN THE UNITED STATES Source text for Eikon: Further company coverage:

BRIEF-Melinta Therapeutics Files For Mixed Shelf Offering Of Upto $150 Million

* MELINTA THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING OF UPTO $150 MILLION - SEC FILING Source text - http://bit.ly/2DSYZpm Further company coverage:

Select another date: